Alcohol drinking status is associated with serum high molecular weight adiponectin in community-dwelling Japanese men

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 9, 2010, Pages 953-962

  Kawamoto, Ryuichi ^a,b   Tabara, Yasuharu ^a   Kohara, Katsuhiko ^a   Miki, Tetsuro ^a   Ohtsuka, Nobuyuki ^b   Kusunoki, Tomo ^a,b   Abe, Asanori ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Seiyo Municipal Nomura Hospital   (Japan)

Author keywords

Alcohol drinking; Confounding factor; HMW adiponectin; Insulin resistance; Men

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH MOLECULAR WEIGHT ADIPONECTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COMMUNITY LIVING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PERIODIC MEDICAL EXAMINATION; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77958570952     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.4879     Document Type: Article

References (35)

1. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB: Adiponectin--a key adipokine in the metabolic syndrome. Diabetes Obes Metab, 2006; 8: 264-280
2. Yamauchi T, Kadowaki T: Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond), 2008; 32: S13-18
3. Chang LC, Huang KC, Wu YW, Kao HL, Chen CL, Lai LP, Hwang JJ, Yang WS: The clinical implications of blood adiponectin in cardiometabolic disorders. J Formos Med Assoc, 2009; 108: 353-366
4. Giannessi D, Maltinti M, Del Ry S: Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk. Pharmacol Res, 2007; 56: 459-467
5. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T: Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem, 2003; 278: 40352-40363
6. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care, 2006; 29: 1357-1362
7. Seino Y, Hirose H, Saito I, Itoh H: High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism, 2007; 56: 1493-1499
8. Tabara Y, Osawa H, Kawamoto R, Tachibana-Iimori R, Yamamoto M, Nakura J, Miki T, Makino H, Kohara K: Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study. J Clin Endocrinol Metab, 2008; 93: 715-722
9. You M, Rogers CQ: Adiponectin: a key adipokine in alcoholic fatty liver. Exp Biol Med, 2009; 234: 850-859
10. Thamer C, Haap M, Fritsche A, Haering H, Stumvoll M: Relationship between moderate alcohol consumption and adiponectin and insulin sensitivity in a large heterogeneous population. Diabetes Care, 2004; 27: 1240
11. Shai I, Rimm EB, Schulze MB, Rifai N, Stampfer MJ, Hu FB: Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men. Diabetologia, 2004; 47: 1760-1767
12. Pischon T, Girman CJ, Rifai N, Hotamisligil GS, Rimm EB: Association between dietary factors and plasma adiponectin concentrations in men. Am J Clin Nutr, 2005; 81: 780-786
13. Englund Ogge L, Brohall G, Behre CJ, Schmidt C, Fagerberg B: Alcohol consumption in relation to metabolic regulation, inflammation, and adiponectin in 64-year-old Caucasian women: a population-based study with a focus on impaired glucose regulation. Diabetes Care, 2006; 29: 908-913
14. Kotani K, Sakane N, Saiga K, Sano Y, Kurozawa Y: Lifestyle-related determinants and serum adiponectin concentrations in a general population of Japanese females. Arch Med Res, 2007; 38: 887-890
15. Yokoyama H, Hirose H, Ohgo H, Saito I: Associations among lifestyle status, serum adiponectin level and insulin resistance. Intern Med, 2004; 43: 453-457
16. Tsukinoki R, Morimoto K, Nakayama K: Association between lifestyle factors and plasma adiponectin levels in Japanese men. Lipids Health Dis, 2005; 4: 27
17. Kotani K, Sakane N, Saiga K, Kato M, Ishida K, Kato Y, Kurozawa Y: Serum adiponectin levels and lifestyle factors in Japanese men. Heart Vessels, 2007; 22: 291-296
18. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985; 28: 412-419
20. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 2001; 86: 1930-1935
21. Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab, 2002; 87: 2764-2769
22. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T: Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension, 2004; 43: 1318-1323
23. Lin J, Hu FB, Curhan G: Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care, 2007; 30: 239-244
24. Kawamoto R, Tabara Y, kohara K, Miki T, Ohtsuka N, Kusunoki T, Abe M: Smoking status Is associated with serum high molecular weight adiponectin in Community-Dwelling Japanese Men. J Atheroscler Thromb, 2010; 17: 423-430
25. Sierksma A, Patel H, Ouchi N, Kihara S, Funahashi T, Heine RJ, Grobbee DE, Kluft C, Hendriks HF: Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care, 2004; 27: 184-189
26. Beulens JW, van Beers RM, Stolk RP, Schaafsma G, Hendriks HF: The effect of moderate alcohol consumption on fat distribution and adipocytokines. Obesity, 2006; 14: 60-66
27. Beulens JW, van Loon LJ, Kok FJ, Pelsers M, Bobbert T, Spranger J, Helander A, Hendriks HF: The effect of moderate alcohol consumption on adiponectin oligomers and muscle oxidative capacity: a human intervention study. Diabetologia, 2007; 50: 1388-1392
28. Joosten MM, Beulens JW, Kersten S, Hendriks HF: Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomized, crossover trial. Diabetologia, 2008; 51: 1375-1381
29. Avogaro A, Sambataro M, Marangoni A, Pianta A, Vettor R, Pagano C, Marescotti MC, Tiengo A, Beltramello G: Moderate alcohol consumption, glucose metabolism and lipolysis: the effect on adiponectin and tumor necrosis factor alpha. J Endocrinol Invest, 2003; 26: 1213-1218
30. Stejskal D, Růzicka V, Fanfrdlova G, Kolar V, Bartek J: High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2005; 149: 93-99
31. Beulens JW, de Zoete EC, Kok FJ, Schaafsma G, Hendriks HF: Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: a diet intervention study. Eur J Clin Nutr, 2008; 62: 1098-1105
32. Imhof A, Plamper I, Maier S, Trischler G, Koenig W: Effect of drinking on adiponectin in healthy men and women: a randomized intervention study of water, ethanol, red wine, and beer with or without alcohol. Diabetes Care, 2009; 32: 1101-1103
33. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ: The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest, 2003; 112: 91-100
34. Lin HZ, Yang SQ, Zeldin G, Diehl AM: Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res, 1998; 22: 231S-237S
35. Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, Radha V: Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism, 2005; 54: 476-481